Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists-Reference-Cited by-同舟云学术

Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists

Published:2023-08-14 Issue:10 Volume:43 Page:1043-1050
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

McCreary Erin K.¹^ORCID,Davis Matthew R.²^ORCID,Narayanan Navaneeth³^ORCID,Andes David R.⁴^ORCID,Cattaneo Dario⁵^ORCID,Christian Robbie⁶,Lewis Russell E.⁷^ORCID,Watt Kevin M.⁸^ORCID,Wiederhold Nathan P.⁹^ORCID,Johnson Melissa D.¹⁰^ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

2. Infectious Disease Connect, Inc. Pittsburgh Pennsylvania USA

3. Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy Rutgers University Piscataway New Jersey USA

4. Departments of Medicine and Medical Microbiology & Immunology University of Wisconsin‐Madison Madison Wisconsin USA

5. Unit of Clinical Pharmacology, Department of Laboratory Medicine Luigi Sacco University Hospital Milan Italy

6. Department of Pharmacy Veterans Affairs Northeast Ohio Healthcare System Cleveland Ohio USA

7. Department of Molecular Medicine University of Padua Padua Italy

8. Division of Pediatric Clinical Pharmacology and Division of Critical Care University of Utah Salt Lake City Utah USA

9. Department of Pathology and Laboratory Medicine, Fungus Testing Laboratory University of Texas Health Science Center at San Antonio San Antonio Texas USA

10. Division of Infectious Diseases, Department of Medicine Duke University Medical Center Durham North Carolina USA

Abstract

AbstractTriazole antifungals (i.e., fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole) are commonly used in clinical practice to prevent or treat invasive fungal infections. Most triazole antifungals require therapeutic drug monitoring (TDM) due to highly variable pharmacokinetics, known drug interactions, and established relationships between exposure and response. On behalf of the Society of Infectious Diseases Pharmacists (SIDP), this insight describes the pharmacokinetic principles and pharmacodynamic targets of commonly used triazole antifungals and provides the rationale for utility of TDM within each agent.

Publisher

Wiley

Subject

Pharmacology (medical)

Reference44 articles.

1. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

2. Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018

3. Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections

4. The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

5. Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histoplasmosis in Solid Organ Transplantation;Journal of Fungi;2024-02-02

2. Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic;Journal of Fungi;2024-01-26

3. Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal;Mycopathologia;2024-01-24

4. Recent advances of aggregation‐induced emission in body surface organs;Aggregate;2023-12-13

5. Approach to diagnostic evaluation and prevention of invasive fungal disease in patients prior to allogeneic hematopoietic stem cell transplant;Transplant Infectious Disease;2023-11